Christopher L. Doerksen

Mining & Energy

• Represented one of the world's largest uranium companies in domestic and offshore acquisitions, dispositions and equity and debt financings aggregating more than $7 billion.
• Represented a gold company in SEC reporting, corporate governance, an NYSE American listing and a series of equity and debt financings and acquisitions totaling over $4 billion that transformed the company from a privately-held exploration stage company into a large, publicly-traded producer.
• Represented a platinum company in an NYSE American listing, SEC reporting, corporate governance and public and private financings aggregating over $700 million.
• Represented mining companies or their investment banks in several going public transactions in which privately-held, U.S.-based mining companies went public via a reverse takeover of a Canadian public company and a concurrent equity financing.

Life Sciences

• Represented a supplier to the life sciences industry in a transformative transaction in which the company completed a $15 million public offering of common stock and warrants, converted $14 million of secured debt into equity, and uplisted from the OTCQB to the NASDAQ Capital Market, as well as in other matters including SEC reporting and corporate governance.
• Represented a biopharmaceutical company in several VC financings, a going public transaction via the takeover of a NASDAQ-listed company, SEC reporting, NASDAQ corporate governance and a $50 million shelf takedown of common stock and warrants.
• Represented a medical device company in SEC reporting and nearly $50 million in equity financings.

Technology and Clean Tech

• Represented a solar lighting company in a series of public and private equity financings and an acquisition in Florida.
• Represented a California-based solar roofing company in an inversion transaction in which the company went public via a reverse takeover of a Canadian public company, concurrent with a $45 million equity financing.
• Represented a satellite imaging company in a going public M&A transaction and a series of financings.

Other Industries

• Represented a consumer lending company in a series of high yield debt, convertible debt and equity offerings in excess of $1 billion.
• Represented the world’s largest industrial auctioneer in SEC reporting, NYSE compliance, corporate governance, stock based compensation, and M&A related matters. 
• Represented a chain of vitamin and supplement stores in a $50 million sale of the company.
• Represented a sandwich chain in its initial public offering on NASDAQ.
• Represented the controlling stakeholder of one of the world's largest commercial real estate brokerage firms in the reorganization of the firm's international governing structure and the relicensing of its operations throughout the U.S.